HTSI

Variability in Intravenous Medication Practices: Implications for Medication Safety

Bates, D.W., Vanderveen, T., Seger, D., Yamaga, C., & Rothschild, J. (April 2008). Joint Commission Journal on Quality and Patient Safety, 31:4, 203-210(8).

Abstract

Data from 100 hospitals indicate a high degree of variability for intravenous drugs, with the variation in concentrations, dose units, and dose limits creating the greatest safety risks.

BACK TO PREVIOUS PAGE